Clinical Trial Update: Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating intratumoral REOLYSIN in combination with gemcitabine and cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• REOLYSIN (pelareorep)

Snippet

Sponsor: Oncolytics Biotech | Conditions: Muscle-invasive Transitional Cell Carcinoma of the Bladder | Phase 1 | Status: WITHDRAWN